Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
Product Unit Size | Cost | Quantity | Stock |
---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
Cas No. | 878419-78-4 |
---|---|
Purity | ≥98% |
Formula | C14H10F3N5O2 |
Formula Wt. | 337.26 |
IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
Solubility | DMSO: 11.5 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
AMPK activator.
Dihydropyridine; L-type and T-type Ca2+ channel...
Dipeptide; aminopeptidase (N/CD13) inhibitor.
Peptide, GnRH analog; GnRH agonist.
CHK1 inhibitor.
2-methyl-1,4-naphthoquinone derivative
Melatonin analog; MT1/2 agonist, 5-HT2C antagon...
Coumarin glucoside found in Aesculus, Daphne, a...
SIRT1/2 inhibitor.
Protein synthesis inhibitor, DPP2 and metallope...
Induces activation of Nrf2; inhibits apoptosis ...
EGFR inhibitor.
DPP4 inhibitor.
Bactericidal
Caspase 3 substrate.
CB1 agonist, TRPV1 agonist.
Notch inhibitor.
beta-catenin inhibitor
Anionic lipopeptide, alters cell membrane organ...
β-lactam; penicillin binding protein inhibitor...